We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Clearwater Paper
CLW
$278M
| $383K | 0.06% |
7,888
-16,157
| -67% | -$674K |
|
552
Corcept Therapeutics
CORT
$9.78B
| $383K | 0.06% |
81,788
-356,583
| -81% | -$1.39M |
|
|
SHLM
553
DELISTED
Schulman (A.) Inc
SHLM
| $381K | 0.05% |
+13,994
| New | +$352K |
|
|
CET
554
Central Securities Corp
CET
$1.55B
| $380K | 0.05% |
19,878
+5,878
| +42% | +$106K |
|
|
AFAM
555
DELISTED
Almost Family Inc
AFAM
| $379K | 0.05% |
10,187
-16,154
| -61% | -$603K |
|
556
Barnes & Noble Education
BNED
$445M
| $378K | 0.05% |
+386
| New | +$387K |
|
|
CXP
557
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $378K | 0.05% |
+17,169
| New | +$370K |
|
|
CARB
558
DELISTED
Carbonite Inc
CARB
| $377K | 0.05% |
47,255
+10,169
| +27% | +$83K |
|
559
Entravision Communication
EVC
$1.02B
| $374K | 0.05% |
+50,306
| New | +$371K |
|
560
Cohen & Steers Infrastructure Fund
UTF
$3.1B
| $374K | 0.05% |
+18,868
| New | +$345K |
|
561
Natera
NTRA
$37B
| $373K | 0.05% |
+39,170
| New | +$331K |
|
562
RingCentral
RNG
$4.5B
| $373K | 0.05% |
+23,667
| New | +$443K |
|
|
HTO
563
H2O America
HTO
$2.66B
| $372K | 0.05% |
+10,240
| New | +$345K |
|
|
OME
564
DELISTED
Omega Protein
OME
| $371K | 0.05% |
+21,916
| New | +$449K |
|
565
Brink's
BCO
$4.86B
| $369K | 0.05% |
+10,993
| New | +$323K |
|
566
Oil-Dri
ODC
$1.43B
| $369K | 0.05% |
+21,860
| New | +$393K |
|
|
EOI
567
Eaton Vance Enhanced Equity Income Fund
EOI
$806M
| $367K | 0.05% |
+29,318
| New | +$362K |
|
568
James River Group Holdings
JRVR
$217M
| $367K | 0.05% |
11,381
-28,699
| -72% | -$920K |
|
569
Stratus Properties
STRS
$159M
| $367K | 0.05% |
+15,427
| New | +$338K |
|
570
eHealth
EHTH
$43.2M
| $365K | 0.05% |
38,894
-47,230
| -55% | -$469K |
|
571
Travelzoo
TZOO
$105M
| $365K | 0.05% |
44,891
-66,010
| -60% | -$513K |
|
|
LCI
572
DELISTED
Lannett Company, Inc.
LCI
| $365K | 0.05% |
+5,089
| New | +$539K |
|
|
USG
573
DELISTED
Usg
USG
| $365K | 0.05% |
+14,700
| New | +$306K |
|
|
TCF
574
DELISTED
TCF Financial Corporation Common Stock
TCF
| $364K | 0.05% |
10,209
-107,888
| -91% | -$3.59M |
|
|
NML
575
Neuberger Energy Infrastructure and Income Fund Inc
NML
$582M
| $361K | 0.05% |
+51,870
| New | +$349K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.